 |
|
|
|
home / corporate / management
 Management
Dobrin Nedelkov, Ph.D.,
Interim CEO, and Director of Research and Technology Development
Prior to joining IBI in the spring of 1999, Dr. Nedelkov was a Postdoctoral Associate at Yale University in the Department of Molecular Biophysics and Biochemistry. Dr. Nedelkov received his Ph.D. in Chemistry and Biochemistry from the Arizona State University in 1997 and his BS in Biotechnology and Food Engineering from Cyril and Methodius University in Skopje, Macedonia in 1993. As a result of his involvement in the application of affinity-based mass spectrometry approaches for high-throughput protein analysis, Dr. Nedelkov introduced the concept of Population Proteomics as a paradigm shift in the study of protein diversity in human populations. In population proteomics human proteins are investigated across and within populations to delineate and understand protein differences, with the ultimate goal of discovering disease-specific protein modulations. Dr. Nedelkov has authored over 50 peer reviewed scientific articles, presented at over 30 scientific meetings, and served as a reviewer on over 20 NIH scientific panel. He is also a co-author on several patent applications, and Principal Investigator on a number of NIH-funded projects.
Past Management
Randall W. Nelson, Ph.D.,
Founder and President
Dr. Nelson founded IBI in 1996 and has served as its President and CEO until 2007. Prior to forming IBI, Dr. Nelson served on the faculty in the Department of Chemistry/Biochemistry at Arizona State University, where he received his Ph.D. in Analytical Chemistry in 1990. Dr. Nelson served from 1990-1993 as MALDI-TOF MS product manager at Vestec Corporation, Houston, TX, where he directed the manufacture of the world's first commercial MALDI-TOF line of mass spectrometers. Dr. Nelson holds numerous patents in the field of biological mass spectrometry and has authored over 70 publications and given numerous talks in the field of biological mass spectrometry. Dr. Nelson is currently a Research Professor and Director of the Molecular Biosignatures Analysis Unit at The Biodesign Institute, Arizona State University.
|
|
 |
|
|
